Back to Search

Breaking Convention: Psychedelic Pharmacology for the 21st Century

PUBLISHER Strange Attractor Press (09/29/2017)
PRODUCT TYPE Paperback (Paperback)

Description
Interdisciplinary essays on psychedelic consciousness.

Presenting an interdisciplinary selection of twenty-five essays first delivered at Breaking Convention 2015, the third conference on psychedelic consciousness, culture, and clinical research, held at the University of Greenwich, London.

Breaking Convention is the largest symposium of its kind, featuring more than 120 academic presentations biennially. Widely regarded as one of the foremost global platforms for serious research into psychedelic pharmacology, the conference has been instrumental in altering popular attitudes towards policy reform, with research focusing on the potential benefits that psychedelic therapies might hold in the treatment of depression, post-traumatic stress disorder, and in harm reduction among habitual substance abusers.

Psychedelic Pharmacology for the 21st Century spans the sciences and humanities, from philosophy and neuroscience through chemical models of action to clinical use. This latest volume includes cross-cultural approaches exploring the global drug economy, clinical MDMA trials, histories of psychedelic literature, the enigma of the pineal gland, acid mediumship and psychedelic landscaping.

Contributors
Allan Badiner, Rick Doblin, Amanda Feilding, Ido Hartogsohn, Jennifer Lyke, Dale Pendell, Iker Puente

Show More
Product Format
Product Details
ISBN-13: 9781907222559
ISBN-10: 1907222553
Binding: Paperback or Softback (Trade Paperback (Us))
Content Language: English
More Product Details
Page Count: 346
Carton Quantity: 16
Product Dimensions: 5.80 x 1.10 x 8.20 inches
Weight: 1.10 pound(s)
Feature Codes: Price on Product
Country of Origin: GB
Subject Information
BISAC Categories
Medical | Pharmacology
Medical | Psychotherapy - General
Medical | General
Grade Level: College Freshman and up
Descriptions, Reviews, Etc.
publisher marketing
Interdisciplinary essays on psychedelic consciousness.

Presenting an interdisciplinary selection of twenty-five essays first delivered at Breaking Convention 2015, the third conference on psychedelic consciousness, culture, and clinical research, held at the University of Greenwich, London.

Breaking Convention is the largest symposium of its kind, featuring more than 120 academic presentations biennially. Widely regarded as one of the foremost global platforms for serious research into psychedelic pharmacology, the conference has been instrumental in altering popular attitudes towards policy reform, with research focusing on the potential benefits that psychedelic therapies might hold in the treatment of depression, post-traumatic stress disorder, and in harm reduction among habitual substance abusers.

Psychedelic Pharmacology for the 21st Century spans the sciences and humanities, from philosophy and neuroscience through chemical models of action to clinical use. This latest volume includes cross-cultural approaches exploring the global drug economy, clinical MDMA trials, histories of psychedelic literature, the enigma of the pineal gland, acid mediumship and psychedelic landscaping.

Contributors
Allan Badiner, Rick Doblin, Amanda Feilding, Ido Hartogsohn, Jennifer Lyke, Dale Pendell, Iker Puente

Show More

Editor: Sessa, Ben
DR. BEN SESSA, MBBS BSc MRCPsych is a consultant Child and Adolescent Psychiatrist working in Taunton, Somerset (UK) with the National Deaf Child and Adolescent Mental Health Service. He began publishing in medical journals on the subject of psychedelics as a trainee and since then has spoken nationally and internationally to doctors in a campaign to see these fascinating substances return to the mainstream pharmacopeia where their lives began. In 2008 he became a Research Associate under Prof. David Nutt at Bristol University, where he consulted for the ACMD on MDMA before working on the UK's only human hallucinogen study in modern times - being the first person to be legally administered a classical psychedelic drug in the UK for 33 years.
Show More
List Price $21.95
Your Price  $21.73
Paperback